Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aminoacyl-tRNA editing activity	IARS1 LARS1 TARS2	4.79e-05	14	104	3	GO:0002161
GeneOntologyMolecularFunction	MHC protein complex binding	HLA-DRB1 HLA-DRB3 HLA-DRB4 LILRB5	6.06e-05	41	104	4	GO:0023023
GeneOntologyMolecularFunction	peptide antigen binding	HLA-DRB1 HLA-DRB3 HLA-DRB4 MAML1	1.23e-04	49	104	4	GO:0042605
GeneOntologyMolecularFunction	MHC class II protein complex binding	HLA-DRB1 HLA-DRB3 HLA-DRB4	3.67e-04	27	104	3	GO:0023026
GeneOntologyMolecularFunction	acetyl-CoA C-acyltransferase activity	ACAT1 SCP2	5.55e-04	7	104	2	GO:0003988
GeneOntologyBiologicalProcess	aminoacyl-tRNA metabolism involved in translational fidelity	IARS1 LARS1 TARS2	3.53e-05	13	105	3	GO:0106074
GeneOntologyBiologicalProcess	positive regulation of long-term synaptic depression	MAPT IQSEC2 LILRB5	4.48e-05	14	105	3	GO:1900454
GeneOntologyBiologicalProcess	MHC class II protein complex assembly	HLA-DRB1 HLA-DRB3 HLA-DRB4	6.84e-05	16	105	3	GO:0002399
GeneOntologyBiologicalProcess	peptide antigen assembly with MHC class II protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4	6.84e-05	16	105	3	GO:0002503
GeneOntologyBiologicalProcess	myeloid dendritic cell antigen processing and presentation	HLA-DRB1 HLA-DRB3	7.68e-05	3	105	2	GO:0002469
GeneOntologyBiologicalProcess	regulation of translational fidelity	IARS1 LARS1 TARS2	1.17e-04	19	105	3	GO:0006450
GeneOntologyBiologicalProcess	MHC protein complex assembly	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.59e-04	21	105	3	GO:0002396
GeneOntologyBiologicalProcess	regulation of clathrin-dependent endocytosis	NEU3 DGKD SNAP91	1.59e-04	21	105	3	GO:2000369
GeneOntologyBiologicalProcess	peptide antigen assembly with MHC protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.59e-04	21	105	3	GO:0002501
GeneOntologyCellularComponent	MHC class II protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4	8.18e-05	17	106	3	GO:0042613
GeneOntologyCellularComponent	clathrin-coated vesicle membrane	CLTCL1 HLA-DRB1 HLA-DRB3 HLA-DRB4 ATP6V1F SNAP91	1.04e-04	147	106	6	GO:0030665
GeneOntologyCellularComponent	autolysosome membrane	HLA-DRB1 HLA-DRB3	1.52e-04	4	106	2	GO:0120281
GeneOntologyCellularComponent	clathrin-coated endocytic vesicle	CLTCL1 HLA-DRB1 HLA-DRB3 HLA-DRB4 SNAP91	1.64e-04	101	106	5	GO:0045334
GeneOntologyCellularComponent	MHC protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4	3.03e-04	26	106	3	GO:0042611
GeneOntologyCellularComponent	clathrin-coated endocytic vesicle membrane	HLA-DRB1 HLA-DRB3 HLA-DRB4 SNAP91	7.01e-04	79	106	4	GO:0030669
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-DRB1 HLA-DRB3 HLA-DRB4	7.37e-04	35	106	3	GO:0098553
GeneOntologyCellularComponent	presynaptic active zone	IQSEC2 NRXN1 SNAP91 KCNMA1 UNC13C	7.63e-04	141	106	5	GO:0048786
GeneOntologyCellularComponent	coated vesicle membrane	CLTCL1 HLA-DRB1 HLA-DRB3 HLA-DRB4 ATP6V1F SNAP91	8.01e-04	215	106	6	GO:0030662
GeneOntologyCellularComponent	spectrin-associated cytoskeleton	ANK1 SPTBN2	8.96e-04	9	106	2	GO:0014731
GeneOntologyCellularComponent	clathrin-coated vesicle	CLTCL1 HLA-DRB1 HLA-DRB3 HLA-DRB4 ATP6V1F SNAP91	1.32e-03	237	106	6	GO:0030136
GeneOntologyCellularComponent	parallel fiber to Purkinje cell synapse	SPTBN2 SNAP91 UNC13C	1.35e-03	43	106	3	GO:0098688
GeneOntologyCellularComponent	NSL complex	KANSL3 HCFC1	1.36e-03	11	106	2	GO:0044545
GeneOntologyCellularComponent	aminoacyl-tRNA synthetase multienzyme complex	IARS1 LARS1	1.63e-03	12	106	2	GO:0017101
GeneOntologyCellularComponent	lumenal side of membrane	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.86e-03	48	106	3	GO:0098576
GeneOntologyCellularComponent	plasma membrane protein complex	HLA-DRB1 HLA-DRB3 HLA-DRB4 INSRR CHRNB1 SNAP91 AHNAK KCNMA1 DLG3 LILRB5 GP1BA	2.12e-03	785	106	11	GO:0098797
GeneOntologyCellularComponent	excitatory synapse	SPTBN2 NRXN1 SNAP91 UNC13C	2.16e-03	107	106	4	GO:0060076
GeneOntologyCellularComponent	lysosomal membrane	HLA-DRB1 HLA-DRB3 HLA-DRB4 NEU3 ATP6V1F AHNAK ABCC10 WDR24	2.44e-03	462	106	8	GO:0005765
GeneOntologyCellularComponent	lytic vacuole membrane	HLA-DRB1 HLA-DRB3 HLA-DRB4 NEU3 ATP6V1F AHNAK ABCC10 WDR24	2.44e-03	462	106	8	GO:0098852
GeneOntologyCellularComponent	neuromuscular junction	CHRNB1 NRXN1 DLG3 UNC13C	2.55e-03	112	106	4	GO:0031594
GeneOntologyCellularComponent	trans-Golgi network membrane	HLA-DRB1 HLA-DRB3 HLA-DRB4 VPS54	2.55e-03	112	106	4	GO:0032588
Domain	MHC_II_b_N	HLA-DRB1 HLA-DRB3 HLA-DRB4	9.20e-06	8	104	3	PD000328
Domain	MHC_II_b_N	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.38e-05	9	104	3	IPR000353
Domain	MHC_II_beta	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.38e-05	9	104	3	SM00921
Domain	MHC_II_beta	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.38e-05	9	104	3	PF00969
Domain	MHC_II_a/b_N	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.84e-05	14	104	3	IPR014745
Domain	-	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.84e-05	14	104	3	3.10.320.10
Domain	-	STBD1 NTRK1 HLA-DRB1 HLA-DRB3 HLA-DRB4 INSRR IGDCC3 FNDC3A PLXNB2 CADM2 TGM1 LILRB5 HCFC1	7.94e-05	663	104	13	2.60.40.10
Domain	MamL-1	MAML1 MAML3	9.18e-05	3	104	2	SM01275
Domain	Neuroggenic_mastermind-like_N	MAML1 MAML3	9.18e-05	3	104	2	IPR019082
Domain	MamL-1	MAML1 MAML3	9.18e-05	3	104	2	PF09596
Domain	Ig-like_fold	STBD1 NTRK1 HLA-DRB1 HLA-DRB3 HLA-DRB4 INSRR IGDCC3 FNDC3A PLXNB2 CADM2 TGM1 LILRB5 HCFC1	1.49e-04	706	104	13	IPR013783
Domain	Thiolase_acyl_enz_int_AS	ACAT1 SCP2	3.04e-04	5	104	2	IPR020615
Domain	Thiolase_C	ACAT1 SCP2	4.54e-04	6	104	2	PF02803
Domain	Adcy_conserved_dom	ADCY4 ADCY2	4.54e-04	6	104	2	IPR009398
Domain	THIOLASE_2	ACAT1 SCP2	4.54e-04	6	104	2	PS00737
Domain	ITI_HC_C	ITIH1 ITIH6	4.54e-04	6	104	2	IPR010600
Domain	THIOLASE_1	ACAT1 SCP2	4.54e-04	6	104	2	PS00098
Domain	THIOLASE_3	ACAT1 SCP2	4.54e-04	6	104	2	PS00099
Domain	Thiolase_N	ACAT1 SCP2	4.54e-04	6	104	2	IPR020616
Domain	Thiolase_C	ACAT1 SCP2	4.54e-04	6	104	2	IPR020617
Domain	Thiolase_CS	ACAT1 SCP2	4.54e-04	6	104	2	IPR020613
Domain	Thiolase	ACAT1 SCP2	4.54e-04	6	104	2	IPR002155
Domain	DUF1053	ADCY4 ADCY2	4.54e-04	6	104	2	PF06327
Domain	Val/Leu/Ile-tRNA-synth_edit	IARS1 LARS1	4.54e-04	6	104	2	IPR009008
Domain	Thiolase_N	ACAT1 SCP2	4.54e-04	6	104	2	PF00108
Domain	Anticodon_1	IARS1 LARS1	4.54e-04	6	104	2	PF08264
Domain	M/V/L/I-tRNA-synth_anticd-bd	IARS1 LARS1	4.54e-04	6	104	2	IPR013155
Domain	-	IARS1 LARS1	4.54e-04	6	104	2	3.90.740.10
Domain	ITI_HC_C	ITIH1 ITIH6	4.54e-04	6	104	2	PF06668
Domain	aa-tRNA-synth_Ia	IARS1 LARS1	6.33e-04	7	104	2	IPR002300
Domain	tRNA-synt_1	IARS1 LARS1	6.33e-04	7	104	2	PF00133
Domain	-	INTS6L COL22A1 ITIH1 ITIH6	7.74e-04	74	104	4	3.40.50.410
Domain	AC_N	ADCY4 ADCY2	8.41e-04	8	104	2	IPR032628
Domain	Adcy	ADCY4 ADCY2	8.41e-04	8	104	2	IPR030672
Domain	VIT	ITIH1 ITIH6	8.41e-04	8	104	2	PF08487
Domain	VIT	ITIH1 ITIH6	8.41e-04	8	104	2	SM00609
Domain	AC_N	ADCY4 ADCY2	8.41e-04	8	104	2	PF16214
Domain	PH	IQSEC2 SPTBN2 TBC1D2 DGKD PREX2 PLEK2 AKAP13	9.33e-04	278	104	7	SM00233
Domain	PH_DOMAIN	IQSEC2 SPTBN2 TBC1D2 DGKD PREX2 PLEK2 AKAP13	9.53e-04	279	104	7	PS50003
Domain	PH_domain	IQSEC2 SPTBN2 TBC1D2 DGKD PREX2 PLEK2 AKAP13	9.73e-04	280	104	7	IPR001849
Domain	NHL_repeat_subgr	NHLRC2 TRIM32	1.08e-03	9	104	2	IPR013017
Domain	VWFA	INTS6L COL22A1 ITIH1 ITIH6	1.14e-03	82	104	4	PS50234
Domain	MHC_I/II-like_Ag-recog	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.23e-03	38	104	3	IPR011162
Domain	VWA	INTS6L COL22A1 ITIH1 ITIH6	1.24e-03	84	104	4	SM00327
Domain	VIT	ITIH1 ITIH6	1.34e-03	10	104	2	PS51468
Domain	NHL_repeat	NHLRC2 TRIM32	1.34e-03	10	104	2	IPR001258
Domain	VIT	ITIH1 ITIH6	1.34e-03	10	104	2	IPR013694
Domain	NHL	NHLRC2 TRIM32	1.34e-03	10	104	2	PF01436
Domain	-	ACAT1 SCP2	1.34e-03	10	104	2	3.40.47.10
Domain	Thiolase-like	ACAT1 SCP2	1.34e-03	10	104	2	IPR016039
Domain	-	IQSEC2 SPTBN2 TBC1D2 DGKD MTMR10 PREX2 PLEK2 AKAP13	1.54e-03	391	104	8	2.30.29.30
Domain	-	IARS1 LARS1	1.63e-03	11	104	2	1.10.730.10
Domain	Tyr_kinase_rcpt_2_CS	NTRK1 INSRR	1.63e-03	11	104	2	IPR002011
Domain	PH	SPTBN2 TBC1D2 DGKD PREX2 PLEK2 AKAP13	1.78e-03	229	104	6	PF00169
Domain	RECEPTOR_TYR_KIN_II	NTRK1 INSRR	1.95e-03	12	104	2	PS00239
Domain	VWF_A	INTS6L COL22A1 ITIH1 ITIH6	2.28e-03	99	104	4	IPR002035
Domain	NHL	NHLRC2 TRIM32	2.30e-03	13	104	2	PS51125
Domain	PH_dom-like	IQSEC2 SPTBN2 TBC1D2 DGKD MTMR10 PREX2 PLEK2 AKAP13	2.62e-03	426	104	8	IPR011993
Domain	Neurexin-like	CADM2 NRXN1	2.68e-03	14	104	2	IPR003585
Domain	4.1m	CADM2 NRXN1	2.68e-03	14	104	2	SM00294
Domain	tRNAsynth_Ia_anticodon-bd	IARS1 LARS1	3.08e-03	15	104	2	IPR009080
Domain	C1-set	HLA-DRB1 HLA-DRB3 HLA-DRB4	3.39e-03	54	104	3	PF07654
Domain	IGc1	HLA-DRB1 HLA-DRB3 HLA-DRB4	3.75e-03	56	104	3	SM00407
Domain	VWA	COL22A1 ITIH1 ITIH6	3.75e-03	56	104	3	PF00092
Domain	FN3	KIAA0319L INSRR IGDCC3 FNDC3A HCFC1	3.77e-03	185	104	5	SM00060
Domain	A/G_cyclase_CS	ADCY4 ADCY2	3.95e-03	17	104	2	IPR018297
Domain	Ig/MHC_CS	HLA-DRB1 HLA-DRB3 HLA-DRB4	4.14e-03	58	104	3	IPR003006
Domain	Ig_C1-set	HLA-DRB1 HLA-DRB3 HLA-DRB4	4.14e-03	58	104	3	IPR003597
Domain	aa-tRNA-synth_I_CS	IARS1 LARS1	4.43e-03	18	104	2	IPR001412
Domain	-	ADCY4 ADCY2	4.43e-03	18	104	2	3.30.70.1230
Domain	Nucleotide_cyclase	ADCY4 ADCY2	4.43e-03	18	104	2	IPR029787
Domain	IG_MHC	HLA-DRB1 HLA-DRB3 HLA-DRB4	4.56e-03	60	104	3	PS00290
Domain	Guanylate_cyc	ADCY4 ADCY2	4.94e-03	19	104	2	PF00211
Domain	GUANYLATE_CYCLASE_2	ADCY4 ADCY2	4.94e-03	19	104	2	PS50125
Domain	A/G_cyclase	ADCY4 ADCY2	4.94e-03	19	104	2	IPR001054
Domain	GUANYLATE_CYCLASE_1	ADCY4 ADCY2	4.94e-03	19	104	2	PS00452
Domain	CYCc	ADCY4 ADCY2	4.94e-03	19	104	2	SM00044
Domain	AA_TRNA_LIGASE_I	IARS1 LARS1	4.94e-03	19	104	2	PS00178
Domain	ZF_DAG_PE_1	DGKD AKAP13 UNC13C	5.46e-03	64	104	3	PS00479
Domain	ZF_DAG_PE_2	DGKD AKAP13 UNC13C	5.46e-03	64	104	3	PS50081
Pathway	BIOCARTA_BBCELL_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.71e-05	11	79	3	M22030
Pathway	BIOCARTA_EOSINOPHILS_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.71e-05	11	79	3	M22048
Pathway	BIOCARTA_IL5_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	4.65e-05	13	79	3	M18928
Pathway	BIOCARTA_MHC_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.90e-05	14	79	3	M22023
Pathway	BIOCARTA_TCRA_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.90e-05	14	79	3	M10765
Pathway	BIOCARTA_BLYMPHOCYTE_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.90e-05	14	79	3	M1473
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION	HLA-DRB1 HLA-DRB3 HLA-DRB4	7.34e-05	15	79	3	M47588
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES	HLA-DRB1 HLA-DRB3 HLA-DRB4	7.34e-05	15	79	3	M47604
Pathway	BIOCARTA_ASBCELL_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	7.34e-05	15	79	3	M7298
Pathway	BIOCARTA_CSK_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.42e-04	22	79	3	M6327
Pathway	BIOCARTA_CTLA4_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.42e-04	22	79	3	M1467
Pathway	BIOCARTA_TH1TH2_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.77e-04	23	79	3	M6705
Pathway	REACTOME_PD_1_SIGNALING	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.02e-04	28	79	3	M18810
Pathway	BIOCARTA_INFLAM_PATHWAY	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.57e-04	29	79	3	M6910
Pathway	KEGG_ASTHMA	HLA-DRB1 HLA-DRB3 HLA-DRB4	6.17e-04	30	79	3	M13950
Pathway	REACTOME_NRCAM_INTERACTIONS	ANK1 DLG3	6.39e-04	7	79	2	M27378
Pathway	KEGG_CELL_ADHESION_MOLECULES_CAMS	HLA-DRB1 HLA-DRB3 HLA-DRB4 NRXN1 GLG1	8.94e-04	133	79	5	M16476
Pubmed	HLA-DR genotypes influence age at disease onset in children and juveniles with type 1 diabetes mellitus.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.91e-08	3	108	3	20371654
Pubmed	Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.91e-08	3	108	3	16815190
Pubmed	Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese.	HLA-DRB1 HLA-DRB4 SOD2	2.91e-08	3	108	3	10425186
Pubmed	Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.91e-08	3	108	3	8775462
Pubmed	A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.91e-08	3	108	3	12008082
Pubmed	Allelic variation in the DR subregion of the human major histocompatibility complex.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.16e-07	4	108	3	3476943
Pubmed	HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.16e-07	4	108	3	14677183
Pubmed	Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.16e-07	4	108	3	19922436
Pubmed	Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.16e-07	4	108	3	26740600
Pubmed	Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB11501-DQB10602--positive subjects.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.16e-07	4	108	3	17002906
Pubmed	HLA-DRB alleles and systemic lupus erythematosus in Jamaicans.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.16e-07	4	108	3	12144077
Pubmed	Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.16e-07	4	108	3	18520346
Pubmed	HLA DR B104, 07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.16e-07	4	108	3	15795121
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	IRF2BP2 TRPS1 MAML1 CHD8 UBN2 CIC KANSL3 YLPM1 HCFC1	1.68e-07	268	108	9	33640491
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	NES ACAT1 IARS1 HNRNPM LARS1 DGKD CHD8 PLEK2 TGM1 FBXL18 TRIM32 FANCI AHNAK DDX18 PPP1R37 AKAP13 PHIP KPNB1	1.88e-07	1353	108	18	29467282
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SLF1 ACAT1 HNRNPM CHD8 ICE1 UBN2 CIC SNAP91 FANCI AHNAK DDX18 YLPM1 HCFC1 PHIP KPNB1	2.74e-07	954	108	15	36373674
Pubmed	Antinuclear antibodies and HLA class II alleles in Jamaican patients with systemic lupus erythematosus.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	17910142
Pubmed	Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	16973583
Pubmed	Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	1970352
Pubmed	Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	7645219
Pubmed	A comparison of HLA-DR and -DQ allele and haplotype frequencies in Trinidadian populations of African, South Asian, and mixed ancestry.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	12392858
Pubmed	Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	15908298
Pubmed	HLA-DQ8 and the HLA-DQ8-DR4 haplotype are positively associated with the hevein-specific IgE immune response in health care workers with latex allergy.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	12209103
Pubmed	HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	17182961
Pubmed	HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	17763415
Pubmed	NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	11782380
Pubmed	Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	23152536
Pubmed	HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	17411376
Pubmed	Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	17507489
Pubmed	Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	7734415
Pubmed	Visual hallucinations and HLA class II antigens in cortical dementia.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	20606439
Pubmed	HLA-DR and DQB1 gene polymorphism in the North-western Colombian population.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	12144632
Pubmed	HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.90e-07	5	108	3	12202216
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CLTCL1 KIAA0319L MAML1 CHD8 ICE1 PLXNB2 CIC KANSL3 FANCI AHNAK ZNF500 AKAP13 HAS3 HCFC1 ABCC10 WDR24	3.18e-07	1105	108	16	35748872
Pubmed	Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	18223493
Pubmed	Long-range linkage on chromosome 6p of VEGF, FKBP5, HLA and TNF alleles associated with transplant rejection.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	19233472
Pubmed	Association of immune responses to mycobacterium tuberculosis peptide antigens with host genetic factors.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	17153701
Pubmed	MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	18305173
Pubmed	HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	15902698
Pubmed	Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	3372263
Pubmed	HLA risk markers for chronic myelogenous leukemia in Eastern Canada.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	19235017
Pubmed	A comparison of molecular HLA-DR and DQ allele profiles forming DR51-, DR52-, and DR53-related haplotypes in five ethnic Thai populations from mainland southeast Asia.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	11082517
Pubmed	Complete coding sequences and haplotypic associations of HLA-B0707, -B1524, -B4405, -B4802, -DRB10409, -DRB10411, -DRB11115, -DRB11305, and the novel allele -DRB1*0709. Group-specific amplification of cDNA from DRB1 alleles associated to DRB3 and DRB4.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	15896200
Pubmed	HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsets.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	11997714
Pubmed	HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.78e-07	6	108	3	14508706
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	IRF2BP2 ANK1 IARS1 TRPS1 TBC1D2 CHD8 LOXL2 AHNAK KPNB1	1.01e-06	332	108	9	37433992
Pubmed	Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.01e-06	7	108	3	18569076
Pubmed	The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.01e-06	7	108	3	1905983
Pubmed	Human macrophages accumulate HIV-1 particles in MHC II compartments.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.01e-06	7	108	3	12230470
Pubmed	[Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis].	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.01e-06	7	108	3	18846964
Pubmed	The impact of anti-HY responses on outcome in current and subsequent pregnancies of patients with recurrent pregnancy losses.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.01e-06	7	108	3	20307907
Pubmed	Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.61e-06	8	108	3	19223392
Pubmed	Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.61e-06	8	108	3	16405603
Pubmed	HLA-A, B, Cw, DRB1, DRB3/4/5, DQB1 in German patients suffering from rapidly progressive periodontitis (RPP) and adult periodontitis (AP).	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.61e-06	8	108	3	12296785
Pubmed	Human leukocyte antigen class I and class II allele frequencies and HIV-1 infection associations in a Chinese cohort.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.61e-06	8	108	3	17106278
Pubmed	Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation.	HLA-DRB1 HLA-DRB3 HLA-DRB4	1.61e-06	8	108	3	23729440
Pubmed	Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.41e-06	9	108	3	24505475
Pubmed	Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane.	HLA-DRB1 HLA-DRB3 HLA-DRB4	2.41e-06	9	108	3	23170932
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	NES STBD1 MAML1 HLCS FNDC3A ATP6V1F ICE1 NHLRC2 CLMN YLPM1 AKAP13 HCFC1	3.09e-06	733	108	12	34672954
Pubmed	Defining the membrane proteome of NK cells.	CLTCL1 IARS1 HLA-DRB1 HLA-DRB3 HNRNPM FNDC3A TBC1D10C GLG1 FANCI AHNAK DDX18 SCP2 AKAP13 HCFC1 KPNB1	3.37e-06	1168	108	15	19946888
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CPAMD8 MAPT TRPS1 VPS54 TARS2 UBN2 KANSL3 THRA CLMN LOXL2 KCNMA1 SCP2 AKAP13 PNPLA7 ALDH3B2 MAML3 INVS	3.42e-06	1489	108	17	28611215
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	ANK1 MAPT SPTBN2	3.44e-06	10	108	3	22159418
Pubmed	Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.	HLA-DRB1 HLA-DRB3 HLA-DRB4	3.44e-06	10	108	3	15784911
Pubmed	Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation.	HLA-DRB1 HLA-DRB3 HLA-DRB4	3.44e-06	10	108	3	12956878
Pubmed	HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6.	HLA-DRB1 HLA-DRB3 HLA-DRB4	3.44e-06	10	108	3	8450224
Pubmed	Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.	HLA-DRB1 HLA-DRB3 HLA-DRB4	4.72e-06	11	108	3	21085635
Pubmed	Intracellular overexpression of HIV-1 Nef impairs differentiation and maturation of monocytic precursors towards dendritic cells.	HLA-DRB1 HLA-DRB3 HLA-DRB4	4.72e-06	11	108	3	22808111
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	CLTCL1 IARS1 IQSEC2 SPTBN2 TRPS1 LARS1 TARS2 PLXNB2 TGM1 FANCI AHNAK ABCC10 GP1BA	6.15e-06	925	108	13	28986522
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NES ACAT1 SPTBN2 CHD8 FANCI AHNAK DDX18 YLPM1 HCFC1 PHIP KPNB1	6.25e-06	653	108	11	22586326
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CLTCL1 ACAT1 IARS1 HNRNPM LARS1 CHD8 NHLRC2 GLG1 AHNAK DDX18 AKAP13 KPNB1	8.18e-06	807	108	12	30575818
Pubmed	Human transcription factor protein interaction networks.	IRF2BP2 SLF1 IARS1 TRPS1 LARS1 MAML1 CHD8 UBN2 MIER1 CIC KANSL3 SAMD11 DDX18 YLPM1 HCFC1 MNT	8.75e-06	1429	108	16	35140242
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NES IQSEC2 SPTBN2 HNRNPM CHD8 UBN2 ITIH1 NRXN1 SNAP91 YLPM1 KCNMA1 DLG3 KPNB1	9.44e-06	963	108	13	28671696
Pubmed	Two distinct subtypes of the HLA-DRw12 haplotypes in the Japanese population detected by nucleotide sequence analysis and oligonucleotide genotyping.	HLA-DRB1 HLA-DRB4	9.55e-06	2	108	2	2592019
Pubmed	Paediatric celiac patients carrying the HLA-DR7-DQ2 and HLA-DR3-DQ2 haplotypes display small clinical differences.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	24628273
Pubmed	Structural comparison of the genes of two HLA-DR supertypic groups: the loci encoding DRw52 and DRw53 are not truly allelic.	HLA-DRB1 HLA-DRB4	9.55e-06	2	108	2	3596674
Pubmed	Mutations and selection in the generation of class II histocompatibility antigen polymorphism.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	6589154
Pubmed	DRB1*03 diversity and DRB3 associations in five major population groups in the United States.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	11872240
Pubmed	Structural organization of the DR subregion of the human major histocompatibility complex.	HLA-DRB1 HLA-DRB4	9.55e-06	2	108	2	3860851
Pubmed	A cellular and functional split in the DRw8 haplotype is due to a single amino acid replacement (DR beta ser 57- asp 57).	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	2497068
Pubmed	HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy.	HLA-DRB1 HLA-DRB4	9.55e-06	2	108	2	19487610
Pubmed	HLA-DR association in papillary thyroid carcinoma.	HLA-DRB1 HLA-DRB4	9.55e-06	2	108	2	20164547
Pubmed	β-III spectrin underpins ankyrin R function in Purkinje cell dendritic trees: protein complex critical for sodium channel activity is impaired by SCA5-associated mutations.	ANK1 SPTBN2	9.55e-06	2	108	2	24603075
Pubmed	The conundrum of HLA-DRB114:01/14:54 and HLA-DRB302:01/02:02 mismatches in unrelated hematopoietic SCT.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	20972469
Pubmed	Identification of a novel HLA-DRB1 allele (HLA-DRB1111902).	HLA-DRB1 HLA-DRB4	9.55e-06	2	108	2	15982264
Pubmed	The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.	NTRK1 SOD2	9.55e-06	2	108	2	24736663
Pubmed	Development of a new HLA-DRB real-time PCR typing method.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	15620466
Pubmed	Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes.	HLA-DRB3 HLA-DRB4	9.55e-06	2	108	2	3110774
Pubmed	Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study.	HLA-DRB1 HLA-DRB4	9.55e-06	2	108	2	15140072
Pubmed	Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	16320316
Pubmed	Description of two new HLA-DRB alleles (DRB10310 and DRB301012) found in a Spanish infant.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	9234492
Pubmed	T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.	HLA-DRB1 HLA-DRB4	9.55e-06	2	108	2	15188377
Pubmed	Tracking antigen-specific T-cells during clinical tolerance induction in humans.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	20543955
Pubmed	Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	16200610
Pubmed	HLA-DRB115:01 and HLA-DRB302:02 in PLA2R-Related Membranous Nephropathy.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	28028136
Pubmed	HLA-DRB1 and -DRB3 allele frequencies and haplotypic associations in Koreans.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	15041167
Pubmed	The unusual DRB108:01 haplotype carrying DRB302:02 confirmed in a Dutch family.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	23742216
Pubmed	Compound heterozygosity of HLA-DRB301:01 and HLA-DRB401:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.	HLA-DRB3 HLA-DRB4	9.55e-06	2	108	2	22671039
Pubmed	Mitochondrial oxidative stress causes hyperphosphorylation of tau.	MAPT SOD2	9.55e-06	2	108	2	17579710
Pubmed	Regulation and immunohistochemical localization of betagamma-stimulated adenylyl cyclases in mouse hippocampus.	ADCY4 ADCY2	9.55e-06	2	108	2	9870949
Pubmed	Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.	HLA-DRB1 HLA-DRB3	9.55e-06	2	108	2	30282837
Interaction	ALDOC interactions	MAPT NTRK1 NHLRC2 LOXL2 UMPS HCFC1 SOD2	9.23e-06	140	106	7	int:ALDOC
Interaction	PKM interactions	ACAT1 MAPT NTRK1 HLA-DRB1 HLA-DRB3 HLA-DRB4 FNDC3A CIC NRXN1 LOXL2 SOD2 INVS	1.19e-05	497	106	12	int:PKM
Interaction	ATP1B1 interactions	ACAT1 MAPT NTRK1 HLA-DRB1 HLA-DRB3 HLA-DRB4 KIAA0319L	2.90e-05	167	106	7	int:ATP1B1
Interaction	TNIK interactions	NES MAPT IQSEC2 SPTBN2 CHD8 UBN2 INTS10 SNAP91 KCNMA1 DLG3	3.30e-05	381	106	10	int:TNIK
Interaction	MEX3A interactions	IRF2BP2 ANK1 IARS1 NTRK1 TRPS1 TBC1D2 CHD8 LOXL2 AHNAK KPNB1	3.52e-05	384	106	10	int:MEX3A
Interaction	NT5C2 interactions	MAPT NTRK1 GLYCTK NHLRC2 PREX2 KPNB1	3.58e-05	117	106	6	int:NT5C2
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAPT VPS54 PREX2 YLPM1 PPP1R37 DLG3 HCFC1	6.95e-06	181	71	7	694
GeneFamily	C1-set domain containing	HLA-DRB1 HLA-DRB3 HLA-DRB4	5.97e-04	42	71	3	591
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY4 ADCY2	6.70e-04	10	71	2	53
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-DRB1 HLA-DRB3 HLA-DRB4	6.85e-04	44	71	3	588
GeneFamily	X-linked mental retardation\|Angiotensin receptors	IQSEC2 DLG3 HCFC1	1.18e-03	53	71	3	103
GeneFamily	Integrator complex	INTS6L INTS10	1.54e-03	15	71	2	1366
GeneFamily	Aminoacyl tRNA synthetases, Class I	IARS1 LARS1	2.49e-03	19	71	2	131
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN	HLA-DRB1 HLA-DRB3 HLA-DRB4 ICE1 CLMN AHNAK YLPM1 AKAP13 MNT KPNB1	5.65e-06	399	107	10	M40939
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLF1 ACRBP NTRK1 HLCS ADCK2 INTS10 LOXL2	1.30e-07	163	106	7	953a7db7e90a913e81002d2141fbbd5f1fdf2197
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACRBP NTRK1 HLCS LOXL2 MAML3 ABCC10 KPNB1	1.30e-07	163	106	7	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	Control-NK_activated\|Control / Disease condition and Cell class	ADCY4 CLTCL1 USP29 IGDCC3 KCNMA1 HAS3	4.15e-07	119	106	6	0d0bab03d56e269c6e637b0bbeffe9d1491dfc33
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CLTCL1 CAND2 MAPT ADCY2 CHRNB1 UNC13C	1.27e-06	144	106	6	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	CLTCL1 MAPT ADCY2 CHRNB1 UNC13C ITIH6	1.95e-06	155	106	6	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	wk_15-18-Hematologic-Meg-ery-Platelet\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ANK1 ACRBP NTRK1 INSRR DGKD GP1BA	2.34e-06	160	106	6	768f3cefc3ad4cda229e598cce8bde574cf64bb2
ToppCell	droplet-Marrow-BM-1m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 IQSEC2 HLCS CIC PREX2 AHNAK	3.10e-06	168	106	6	2e88d9cb7c80a4656fab290db8b45a5a0599d769
ToppCell	droplet-Marrow-nan-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAND2 IQSEC2 NEU3 TARS2 PLXNB2 INVS	3.80e-06	174	106	6	55cc8300489d11322724159ec7d0e1d32a702e91
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 NTRK1 SPTBN2 INSRR ATP6V1F PLEK2	6.49e-06	191	106	6	feec8617678b778475747ad406c80231e07fd6f7
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	TRPS1 HLCS GOLM1 ADCY2 RAVER2 KCNMA1	8.44e-06	200	106	6	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB5 IGDCC3 PLEK2 SNAP91 KCNMA1	2.21e-05	141	106	5	4aa4b3476dc5abefbd348353cfe711cd5fe3d52f
ToppCell	facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB5 IGDCC3 PLEK2 SNAP91 KCNMA1	2.21e-05	141	106	5	e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8
ToppCell	Adult-Immune-enucleated_erythrocyte-D175\|Adult / Lineage, Cell type, age group and donor	SPTBN2 ADCK2 SLC39A12 NRXN1 TRIM32	3.17e-05	152	106	5	530d5427d8617dcb223d807b73abee0ef89285f3
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EFCAB5 ANK1 NTRK1 CADM2 THRA	3.17e-05	152	106	5	ca23261d8ef263cc697b8d7e7cb2afec8bc564f2
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PREX2 SLC39A12 CLMN PNPLA7 KIAA2012	3.27e-05	153	106	5	95b28c5bd10ffb74c0993ebd565038b9818e4bd2
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PREX2 SLC39A12 CLMN PNPLA7 KIAA2012	3.27e-05	153	106	5	b09f8def40a1ea56722f3398f61a036667b61cd9
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PREX2 SLC39A12 CLMN PNPLA7 KIAA2012	3.27e-05	153	106	5	3ab9d55b3db51715c1d61eca142384195ce4b54f
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	HLCS FANCI SCP2 ABCC10	3.45e-05	77	106	4	ebb1a537751739232820a60f88911877fc683855
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPT MIER1 FBXL18 NRXN1 RAVER2	3.59e-05	156	106	5	d72c2f5f72d269e29033f8728d924e0d4c8772c7
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	EFCAB5 ANK1 PAMR1 NTRK1 CADM2	4.05e-05	160	106	5	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	KIAA0319L NHLRC2 AHNAK SCP2 AKAP13	4.30e-05	162	106	5	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL22A1 ADCY2 CADM2 NRXN1 SNAP91	4.56e-05	164	106	5	be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD13B STBD1 FAR2 FANCI DLG3	5.26e-05	169	106	5	481e611b5fface58f1630f206c0b04fb54e24011
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL22A1 ADCY2 CADM2 NRXN1 SNAP91	5.26e-05	169	106	5	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK1 ADCY2 CADM2 NRXN1 UNC13C	5.56e-05	171	106	5	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKRD13B NES NEU3 CADM2 NRXN1	7.09e-05	180	106	5	c72f15763ba707189e29c85db533557f01c7fdb1
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal-Basal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTBN2 PLEK2 TGM1 LOXL2 ALDH3B2	7.27e-05	181	106	5	6b43dcaeeb02ad5900772b6f16f1581847050e38
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTBN2 PLEK2 TGM1 LOXL2 ALDH3B2	7.27e-05	181	106	5	f50561fdacfb83ba85fe6476e7cbc2bad1ebc826
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	COL22A1 ADCY2 CADM2 NRXN1 SNAP91	7.47e-05	182	106	5	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANKRD13B CIC THRA FBXL18 SERGEF	7.86e-05	184	106	5	a6dee97ee4ef9d89e11d17339e0dadaea1210ce5
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 COL22A1 CADM2 NRXN1 UNC13C	7.86e-05	184	106	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 COL22A1 CADM2 NRXN1 UNC13C	7.86e-05	184	106	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 COL22A1 CADM2 NRXN1 UNC13C	7.86e-05	184	106	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACAT1 NTRK1 INSRR ATP6V1F PLEK2	8.27e-05	186	106	5	c2b65b8345487710704c3eb043e9bef2e2b1ff27
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STBD1 ANK1 CADM2 CHRNB1 CLMN	8.27e-05	186	106	5	1cbb1a1c4f0f6078e9c7b4e0dc93d6b6de7e57db
ToppCell	mild-unassigned\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TGM1 FBXL18 YLPM1 HAS3 WDR24	8.27e-05	186	106	5	5b2e1a58916f392fa1156bf9210df528775248ff
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL22A1 ADCY2 CADM2 NRXN1 SNAP91	8.27e-05	186	106	5	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN2 PLEK2 TBC1D10C FBXL18 WDR24	8.48e-05	187	106	5	22fd1959879705a8c1128faa9de66696c4e0b7e3
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN2 PLEK2 TBC1D10C FBXL18 WDR24	8.48e-05	187	106	5	5fae538de481367cf6d9a2d52190d77b99f6922c
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PAMR1 PREX2 SLC39A12 SAMD11 AHNAK	8.48e-05	187	106	5	401be371b32066db926de3415bb4ce9465749dc3
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN2 PLEK2 TBC1D10C FBXL18 WDR24	8.48e-05	187	106	5	0526c0a818cf28fd5b6ff65fe260e3c3a4a98a2a
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 INSRR UBN2 NRXN1 AKAP13	8.70e-05	188	106	5	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MAPT ADCY2 NRXN1 LOXL2	8.70e-05	188	106	5	a906c29e3fda22eecfec3e5cac706c417bf2b7a4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NES CPAMD8 ADCY4 PREX2 FAR2	8.92e-05	189	106	5	12b6f1c3bf526b90e112374bf937701f645c5780
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACAT1 NTRK1 INSRR ATP6V1F PLEK2	8.92e-05	189	106	5	1fd763c4e9904e866586a506ee7b0b285170481d
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES MAPT ADCY2 NRXN1 LOXL2	9.14e-05	190	106	5	951e067d14412db67dc3babcdf61e41717d7b429
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HLA-DRB1 DGKD SP110 TBC1D10C AKAP13	9.37e-05	191	106	5	a073d58154c801ec499fd969f42b7f1ee7f15d79
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PREX2 CADM2 SLC39A12 NRXN1 PNPLA7	9.60e-05	192	106	5	261211a86e6f63b09c2ddce1d2d9257d311f1770
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-DRB1 IQSEC2 ATP6V1F PLXNB2 AHNAK	1.03e-04	195	106	5	4e9513a7ea69fa9fc8e9ff2da8ef3f44e8fdc70d
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-DRB1 IQSEC2 ATP6V1F PLXNB2 AHNAK	1.03e-04	195	106	5	a25a342380e258b784227f7298f609ccaa1f9ce7
ToppCell	15-Trachea-Epithelial-Epithelial\|Trachea / Age, Tissue, Lineage and Cell class	NES MAPT IGDCC3 CADM2 NRXN1	1.03e-04	195	106	5	9e9283a397f56732a0a5f2e2527f154d4c2dd56a
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 MAPT ADCY2 CHRNB1 CLMN	1.06e-04	196	106	5	3dc6394c5de1f875a19ad0e8799827fad29f8f02
ToppCell	facs-Brain_Non-Myeloid-Cortex\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPT CADM2 SLC39A12 NRXN1 CLMN	1.06e-04	196	106	5	256fe9bc0815f66a9afe11ba3507ef1372b52fd3
ToppCell	COVID-19-Myeloid-Transitioning_MDM\|COVID-19 / group, cell type (main and fine annotations)	TRPS1 FNDC3A CLMN KCNMA1 MAML3	1.06e-04	196	106	5	4929cfed1f150c1fde4d79cb49895c2ea467a18f
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	EFCAB5 ADCY4 AHNAK DLG3 HAS3	1.11e-04	198	106	5	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	proximal-Epithelial-Neuroendocrine\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGDCC3 ITIH1 CADM2 NRXN1 SNAP91	1.11e-04	198	106	5	5dea6078488d584513c0bdbf5bba54877310b54a
ToppCell	proximal-Epithelial-Neuroendocrine-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGDCC3 ITIH1 CADM2 NRXN1 SNAP91	1.11e-04	198	106	5	00ccf3020667cf2130bc354b441b65c0b1b0e862
ToppCell	proximal-3-Epithelial-Neuroendocrine\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGDCC3 ITIH1 CADM2 NRXN1 SNAP91	1.11e-04	198	106	5	a6bc043faf68468d46bac441cf7447c236c7bae4
ToppCell	tumor_Lung-Myeloid_cells-mo-Mac\|tumor_Lung / Location, Cell class and cell subclass	HLA-DRB1 ATP6V1F KCNMA1 LILRB5 SOD2	1.14e-04	199	106	5	77d46acf655029eab23471dc4c4a1b0832b24306
ToppCell	Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	EFCAB5 CAND2 CADM2 NRXN1 FANCI	1.14e-04	199	106	5	a92718a3f1153b8d2196fd343ed5bc0ebc98cad7
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TRPS1 HLCS VPS54 KCNMA1 MAML3	1.14e-04	199	106	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Tracheal-10x3prime_v2-Stromal-Schwann\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	EFCAB5 CAND2 CADM2 NRXN1 FANCI	1.14e-04	199	106	5	8dc65662c3ca1db2ba0091332f0658abc0afc5de
ToppCell	control-Myeloid-CD14_Monocytes_1\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	IRF2BP2 HLA-DRB1 ATP6V1F PLXNB2 AHNAK	1.14e-04	199	106	5	8c14237c3da91d1a4878df489a495408a1e83883
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DRB1 TRPS1 SLC39A12 KCNMA1 LILRB5	1.16e-04	200	106	5	179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DGKD GOLM1 CLMN KCNMA1 PNPLA7	1.16e-04	200	106	5	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HLCS GOLM1 CLMN RAVER2 MAML3	1.16e-04	200	106	5	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HLCS GOLM1 RAVER2 KCNMA1 MAML3	1.16e-04	200	106	5	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	ADCY4 IGDCC3 PREX2 FAR2 UNC13C	1.16e-04	200	106	5	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL22A1 TBC1D10C FANCI LOXL2	1.25e-04	107	106	4	d446ffbe93cd49669f1cf91411aae07cc15d9e2a
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL22A1 TBC1D10C FANCI LOXL2	1.25e-04	107	106	4	5c9e745d0b08a4aa1f3a93f9cc094fac57061a30
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADCY4 USP29 IGDCC3 HAS3	1.82e-04	118	106	4	5f72022f4be3fb7ccec86dc05d37572833028886
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADCY4 USP29 IGDCC3 HAS3	1.82e-04	118	106	4	053c0986051e36fdc4c48b8067c137b6299b2f1b
ToppCell	Control-Lymphoid_T/NK-NK_activated\|Control / Disease group, lineage and cell class	ADCY4 USP29 IGDCC3 HAS3	1.88e-04	119	106	4	a258d91ac90d4174b6f203d7f96ba6e57c6003e7
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADCY4 USP29 IGDCC3 HAS3	1.88e-04	119	106	4	28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADCY4 USP29 IGDCC3 HAS3	1.88e-04	119	106	4	0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2
Drug	Mephenesin [59-47-2]; Down 200; 22uM; PC3; HT_HG-U133A	MAPT PLXNB2 CHRNB1 YLPM1 DLG3 AKAP13 ABCC10 SOD2	3.98e-06	197	106	8	7374_DN
Drug	epicholesterol	ALLC ADCY4 CLTCL1 ACAT1 NEU3 ADCY2 CHRNB1 INTS10 THRA TRIM32 KCNMA1 SCP2 SOD2	8.21e-06	636	106	13	CID000000304
Drug	CAS 66104-23-2	ADCY4 ADCY2 TRIM32 LOXL2 SOD2	1.13e-05	63	106	5	CID000004745
Drug	DMPD	TGM1 KCNMA1 MNT SOD2	1.64e-05	33	106	4	CID000007472
Drug	AC1MPJID	ADCY4 HLA-DRB1 FNDC3A VPS54 ADCY2 TGM1	1.82e-05	117	106	6	CID003386230
Drug	azaleucine	IARS1 LARS1 THRA	2.09e-05	12	106	3	CID000160768
Drug	NSC636979	IARS1 LARS1	2.15e-05	2	106	2	CID000367344
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	CLTCL1 MAPT SPTBN2 KANSL3 FBXL18 SERGEF HCFC1	3.39e-05	193	106	7	4186_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	CLTCL1 IQSEC2 TBC1D2 MAML1 CHRNB1 GLG1 KCNMA1	3.39e-05	193	106	7	4322_UP
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	LARS1 DGKD CLMN GLG1 YLPM1 DLG3 HCFC1	3.50e-05	194	106	7	1670_DN
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A	SPTBN2 KIAA0319L HLCS KANSL3 THRA KCNMA1 HCFC1	3.50e-05	194	106	7	4249_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	NES ADCK2 FNDC3A FBXL18 GLG1 HCFC1 ABCC10	3.74e-05	196	106	7	7226_DN
Drug	Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	CLTCL1 MAPT KIAA0319L KANSL3 THRA SERGEF HCFC1	3.74e-05	196	106	7	4196_DN
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A	KIAA0319L ADCK2 CLMN YLPM1 ZNF500 AKAP13 HCFC1	3.86e-05	197	106	7	7194_DN
Drug	Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A	SPTBN2 KIAA0319L HLCS DGKD FBXL18 GLG1 DLG3	3.86e-05	197	106	7	3334_DN
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; MCF7; HT_HG-U133A	TBC1D2 ADCK2 THRA RAVER2 KCNMA1 AKAP13 HCFC1	3.99e-05	198	106	7	6013_UP
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SPTBN2 TBC1D2 HLCS CIC THRA SERGEF HCFC1	3.99e-05	198	106	7	3882_DN
Drug	Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A	ALLC SPTBN2 NEU3 ADCY2 CHRNB1 THRA KCNMA1	4.12e-05	199	106	7	3402_UP
Disease	neutrophil count	NES CPAMD8 MAPT NTRK1 HLA-DRB1 HLA-DRB3 IQSEC2 MAML1 NHLRC2 TARS2 CIC PREX2 SLC39A12 THRA GLG1 SERGEF AKAP13 UNC13C	1.75e-06	1382	105	18	EFO_0004833
Disease	aspirin-induced respiratory disease (is_implicated_in)	HLA-DRB1 HLA-DRB3 HLA-DRB4	7.08e-06	11	105	3	DOID:0080822 (is_implicated_in)
Disease	polyneuropathy (is_implicated_in)	HLA-DRB1 SOD2	7.49e-05	4	105	2	DOID:1389 (is_implicated_in)
Disease	amyotrophic lateral sclerosis type 1 (implicated_via_orthology)	VPS54 SOD2	7.49e-05	4	105	2	DOID:0060193 (implicated_via_orthology)
Disease	infectious mononucleosis (is_implicated_in)	HLA-DRB1 SOD2	7.49e-05	4	105	2	DOID:8568 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	C5orf67 HLA-DRB1 TRPS1 NHLRC2 INTS10 LILRB5 KPNB1	8.43e-05	291	105	7	EFO_0008317, EFO_0020946
Disease	total lipids in small VLDL	C5orf67 HLA-DRB1 TRPS1 INTS10	9.77e-05	67	105	4	EFO_0022148
Disease	Alzheimer's disease (is_implicated_in)	MAPT NTRK1 HLA-DRB1 KCNMA1 SOD2	1.12e-04	132	105	5	DOID:10652 (is_implicated_in)
Disease	phospholipids in large HDL measurement	C5orf67 HLA-DRB1 TRPS1 INTS10	1.36e-04	73	105	4	EFO_0022190
Disease	total lipids in large HDL	C5orf67 HLA-DRB1 TRPS1 INTS10	1.44e-04	74	105	4	EFO_0022189
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	C5orf67 HLA-DRB1 TRPS1 NHLRC2 INTS10 KPNB1	1.58e-04	225	105	6	EFO_0008317, EFO_0010351
Disease	CREST Syndrome	HLA-DRB1 KIAA0319L	1.86e-04	6	105	2	C0206138
Disease	extranodal nasal NK/T cell lymphoma	HLA-DRB1 HLA-DRB3	1.86e-04	6	105	2	MONDO_0019472
Disease	Scleroderma, Limited	HLA-DRB1 KIAA0319L	1.86e-04	6	105	2	C0748540
Disease	cholesterol in large HDL measurement	C5orf67 HLA-DRB1 TRPS1 INTS10	1.95e-04	80	105	4	EFO_0021900
Disease	Mental Retardation, X-Linked 1	IQSEC2 DLG3 HCFC1	2.01e-04	32	105	3	C2931498
Disease	Congenital Pain Insensitivity	CLTCL1 NTRK1	2.60e-04	7	105	2	C0002768
Disease	Alzheimer disease, educational attainment	MAPT HLA-DRB1 CADM2 NRXN1 PPP1R37 MAML3	2.61e-04	247	105	6	EFO_0011015, MONDO_0004975
Disease	retinal detachment, retinal break	CPAMD8 MAPT COL22A1	2.64e-04	35	105	3	EFO_0005773, EFO_0010698
Disease	Bipolar Disorder	NTRK1 HLA-DRB1 HLA-DRB4 ADCY2 ITIH1 NRXN1 DLG3 SOD2	3.12e-04	477	105	8	C0005586
Disease	Sarcoidosis	HLA-DRB1 SOD2	3.46e-04	8	105	2	C0036202
Disease	Hereditary spherocytosis	ANK1 UMPS	3.46e-04	8	105	2	C0037889
Disease	optic neuritis (is_implicated_in)	HLA-DRB1 SOD2	3.46e-04	8	105	2	DOID:1210 (is_implicated_in)
Disease	high density lipoprotein particle size measurement	C5orf67 HLA-DRB1 TRPS1 NHLRC2 INTS10	3.63e-04	170	105	5	EFO_0008592
Disease	aspartate aminotransferase measurement	C5orf67 MAPT HLA-DRB1 HLA-DRB3 NHLRC2 ITIH1 SLC39A12 AKAP13 KIAA2012 LILRB5 PHIP	3.81e-04	904	105	11	EFO_0004736
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	C5orf67 HLA-DRB1 INTS10 SOD2	3.91e-04	96	105	4	EFO_0004530, EFO_0008317, EFO_0008596
Disease	non-syndromic X-linked intellectual disability (implicated_via_orthology)	IQSEC2 DLG3	4.44e-04	9	105	2	DOID:0050776 (implicated_via_orthology)
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	C5orf67 HLA-DRB1 SOD2	4.54e-04	42	105	3	EFO_0008317, EFO_0008596, EFO_0020945
Disease	waist-hip ratio, high density lipoprotein cholesterol measurement	C5orf67 NHLRC2	5.54e-04	10	105	2	EFO_0004343, EFO_0004612
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	C5orf67 TRPS1 NHLRC2 KPNB1	5.90e-04	107	105	4	EFO_0004614, EFO_0004615
Disease	cortical thickness	ANKRD13B IRF2BP2 CPAMD8 C5orf67 MAPT SPTBN2 TRPS1 FAR2 SNAP91 YLPM1 HAS3 ABCC10	6.06e-04	1113	105	12	EFO_0004840
Disease	free cholesterol in small VLDL measurement	HLA-DRB1 TRPS1 KPNB1	6.34e-04	47	105	3	EFO_0022272
Disease	Macrocephaly	CHD8 THRA	6.76e-04	11	105	2	C0221355
Disease	triglyceride measurement, intermediate density lipoprotein measurement	C5orf67 HLA-DRB1 TRPS1 INTS10	6.77e-04	111	105	4	EFO_0004530, EFO_0008595
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	C5orf67 HLA-DRB1 TRPS1 NHLRC2 INTS10 KPNB1	7.67e-04	303	105	6	EFO_0004612, EFO_0020945
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	C5orf67 HLA-DRB1 INTS10	8.05e-04	51	105	3	EFO_0022302
Disease	glycoprotein measurement	C5orf67 HLA-DRB1 TRPS1 LILRB5	8.78e-04	119	105	4	EFO_0004555
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	C5orf67 HLA-DRB1 TRPS1 NHLRC2 INTS10 LILRB5	9.37e-04	315	105	6	EFO_0004574, EFO_0004612
Disease	diabetic angiopathy (is_implicated_in)	HLA-DRB1 SOD2	9.54e-04	13	105	2	DOID:11713 (is_implicated_in)
Disease	triglycerides in medium VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.00e-03	55	105	3	EFO_0022155
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	C5orf67 HLA-DRB1 TRPS1 INTS10 KPNB1	1.05e-03	215	105	5	EFO_0008317, EFO_0008591
Disease	triglycerides in large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.06e-03	56	105	3	EFO_0022178
Disease	triglycerides in very large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.06e-03	56	105	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	C5orf67 HLA-DRB1 INTS10	1.06e-03	56	105	3	EFO_0022333
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	C5orf67 HLA-DRB1 SOD2	1.06e-03	56	105	3	EFO_0022316
Disease	cholesteryl esters to total lipids in medium HDL percentage	C5orf67 HLA-DRB1 INTS10	1.06e-03	56	105	3	EFO_0022251
Disease	Sarcomatoid Renal Cell Carcinoma	AHNAK KCNMA1 AKAP13 SOD2	1.15e-03	128	105	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	AHNAK KCNMA1 AKAP13 SOD2	1.15e-03	128	105	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	AHNAK KCNMA1 AKAP13 SOD2	1.15e-03	128	105	4	C1266044
Disease	Papillary Renal Cell Carcinoma	AHNAK KCNMA1 AKAP13 SOD2	1.15e-03	128	105	4	C1306837
Disease	Renal Cell Carcinoma	AHNAK KCNMA1 AKAP13 SOD2	1.15e-03	128	105	4	C0007134
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	C5orf67 HLA-DRB1 TRPS1 INTS10 KPNB1	1.16e-03	220	105	5	EFO_0004529, EFO_0008317
Disease	triglycerides in IDL measurement	C5orf67 HLA-DRB1 TRPS1	1.17e-03	58	105	3	EFO_0022149
Disease	triglycerides in VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.23e-03	59	105	3	EFO_0022326
Disease	phospholipids in VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.23e-03	59	105	3	EFO_0022301
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	C5orf67 HLA-DRB1 SOD2	1.23e-03	59	105	3	EFO_0022260
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	C5orf67 HLA-DRB1 TRPS1 INTS10 KPNB1	1.26e-03	224	105	5	EFO_0004574, EFO_0008317
Disease	Non-steroidal anti-inflammatory and antirheumatic product use measurement	HLA-DRB1 MAML3	1.28e-03	15	105	2	EFO_0009935
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	C5orf67 HLA-DRB1 NHLRC2 INTS10 KPNB1	1.28e-03	225	105	5	EFO_0008317, EFO_0020947
Disease	phospholipids in small VLDL measurement	C5orf67 HLA-DRB1 TRPS1	1.29e-03	60	105	3	EFO_0022146
Disease	Sjogren syndrome	HLA-DRB1 HLA-DRB3 PHIP	1.29e-03	60	105	3	EFO_0000699
Disease	triglycerides to total lipids in large HDL percentage	C5orf67 HLA-DRB1 INTS10	1.29e-03	60	105	3	EFO_0022330
Disease	total lipids in VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.29e-03	60	105	3	EFO_0022314
Disease	cholesterol to total lipids in medium HDL percentage	C5orf67 HLA-DRB1 INTS10	1.29e-03	60	105	3	EFO_0022237
Disease	triglycerides in small VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.36e-03	61	105	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.36e-03	61	105	3	EFO_0022274
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	C5orf67 HLA-DRB1 TRPS1 INTS10 KPNB1	1.39e-03	229	105	5	EFO_0004639, EFO_0008317
Disease	triglycerides in small HDL measurement	C5orf67 HLA-DRB1 INTS10	1.42e-03	62	105	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.42e-03	62	105	3	EFO_0022169
Disease	triglycerides to total lipids in very large HDL percentage	C5orf67 HLA-DRB1 INTS10	1.42e-03	62	105	3	EFO_0022339
Disease	total lipids in chylomicrons and extremely large VLDL measurement	C5orf67 HLA-DRB1 SOD2	1.42e-03	62	105	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.42e-03	62	105	3	EFO_0022313
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	C5orf67 HLA-DRB1 SOD2	1.42e-03	62	105	3	EFO_0022263
Disease	APOE carrier status, dementia	IRF2BP2 CADM2 FAR2	1.42e-03	62	105	3	EFO_0007659, MONDO_0001627
Disease	cutaneous melanoma, hair color	C5orf67 PLXNB2 AHNAK	1.42e-03	62	105	3	EFO_0000389, EFO_0003924
Disease	phospholipids in very large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.42e-03	62	105	3	EFO_0022299
Disease	nervousness	CADM2 YLPM1	1.46e-03	16	105	2	NCIT_C74532
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	C5orf67 HLA-DRB1 SOD2	1.49e-03	63	105	3	EFO_0022292
Disease	Profound Mental Retardation	CHD8 CIC NRXN1 PHIP	1.56e-03	139	105	4	C0020796
Disease	Mental Retardation, Psychosocial	CHD8 CIC NRXN1 PHIP	1.56e-03	139	105	4	C0025363
Disease	Mental deficiency	CHD8 CIC NRXN1 PHIP	1.56e-03	139	105	4	C0917816
Disease	cholesterol in large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.63e-03	65	105	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.63e-03	65	105	3	EFO_0022230
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	C5orf67 HLA-DRB1 NHLRC2 INTS10 KPNB1	1.67e-03	239	105	5	EFO_0008317, EFO_0020945
Disease	visceral adipose tissue measurement	C5orf67 TRPS1 COL22A1 ADCY2 CADM2 NRXN1 MAML3	1.69e-03	481	105	7	EFO_0004765
Disease	low density lipoprotein cholesterol measurement, physical activity	TRPS1 DDX18 KPNB1	1.70e-03	66	105	3	EFO_0003940, EFO_0004611
Disease	obesity	DGKD COL22A1 CADM2 DDX18 KCNMA1	1.73e-03	241	105	5	EFO_0001073
Disease	total lipids in large VLDL	C5orf67 HLA-DRB1 INTS10	1.78e-03	67	105	3	EFO_0022175
Disease	cholesterol to total lipids in very small VLDL percentage	C5orf67 HLA-DRB1 INTS10	1.78e-03	67	105	3	EFO_0022245
Disease	nephrotic syndrome (is_marker_for)	SOD2 GP1BA	1.85e-03	18	105	2	DOID:1184 (is_marker_for)
Disease	triglycerides to phosphoglycerides ratio	C5orf67 HLA-DRB1 INTS10	1.86e-03	68	105	3	EFO_0022327
Disease	free cholesterol in large VLDL measurement	C5orf67 HLA-DRB1 INTS10	1.86e-03	68	105	3	EFO_0022265
Disease	congenital heart disease (implicated_via_orthology)	CHD8 ADCY2 HCFC1	1.93e-03	69	105	3	DOID:1682 (implicated_via_orthology)
Disease	testosterone measurement	IRF2BP2 C5orf67 MAPT HLA-DRB1 IQSEC2 TRPS1 GLYCTK CHRNB1 NRXN1 PHIP ABCC10 KPNB1	1.94e-03	1275	105	12	EFO_0004908
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	AHNAK KCNMA1 AKAP13 SOD2	1.96e-03	148	105	4	C0279702
Disease	parental longevity	PAMR1 HLA-DRB1 COL22A1 PLXNB2 SP110 YLPM1 PHIP	1.96e-03	494	105	7	EFO_0007796
Disease	forced expiratory volume	C5orf67 ANK1 HLA-DRB1 SPTBN2 PLXNB2 AHNAK KCNMA1 KIAA2012 PHIP	2.04e-03	789	105	9	EFO_0004314
Disease	hepatitis B virus infection	HLA-DRB1 HLA-DRB3	2.06e-03	19	105	2	EFO_0004197
Disease	colorectal cancer, inflammatory bowel disease	HLA-DRB1 SP110	2.06e-03	19	105	2	EFO_0003767, MONDO_0005575
Disease	Manic Disorder	NTRK1 ADCY2 ITIH1	2.10e-03	71	105	3	C0024713

Protein segments in the cluster

Peptide	Gene	Start	Entry
LLGGIGELNKNRHPN	ATP6V1F	21	Q16864
LHPGNILVQGANGLS	ADCK2	446	Q7Z695
VLGSLPGKIVLQGNQ	CHD8	306	Q9HCK8
GPSHEKGNRIVNGQG	ANKRD20A8P	311	Q5CZ79
SNAKFGHPNNIIGVG	ALLC	211	Q8N6M5
LGGQEQAPEHKQEQG	ACRBP	186	Q8NEB7
GNLGNKSGLTPLHLV	ANK1	661	P16157
KPGGRGALSIHNQEG	AKAP13	186	Q12802
LQTGLGPDGQGHQEI	CHRNB1	181	P11230
ASGPELQGAGHSKLQ	AHNAK	231	Q09666
GLNHGPVVAGVIGAQ	ADCY4	986	Q8NFM4
HLNTLEGKKPGNNEG	SNAP91	281	O60641
LGGPQETGQLLEHKL	ALDH3B2	86	P48448
IAGQAGPGHSNTQEK	RAVER2	496	Q9HCJ3
PQEIGIKVKNHSGGG	INTS6L	446	Q5JSJ4
QEGGKIHLELLPNQG	INTS10	641	Q9NVR2
LGIAEQHGGPQNGTL	ANKRD13B	311	Q86YJ7
QHGGPQNGTLITQTL	ANKRD13B	316	Q86YJ7
GQQGVTQVVLKGAPG	HCFC1	826	P51610
NINGPNGIIIATGKG	FAR2	246	Q96K12
QQLKETGHVSGPDGQ	FANCI	851	Q9NVI1
GLSQQHNKGTLNPGL	MAML1	806	Q92585
LVQHQQGLANPGLVG	ABCC10	1171	Q5T3U5
GLGGVPEQKLQCHGQ	NTRK1	166	P04629
GKGSGLQGHIIENPQ	NTRK1	481	P04629
TIIIGGKEQGQPFQG	NRXN1	246	P58400
NGQVLGPGGHVRLKN	IGDCC3	366	Q8IVU1
GPGGHVRLKNNNSTL	IGDCC3	371	Q8IVU1
INPGNHLKIQEGTLG	KCNMA1	646	Q12791
GAGTGKQQHPSKPQQ	MAML3	126	Q96JK9
NGQLIGNKARSPGQH	ITIH1	711	P19827
HNSANKINGIPSGDG	MTMR10	186	Q9NXD2
KGKLLHGQNGSVPNG	KIAA0319L	1021	Q8IZA0
HGQNGSVPNGQTPLK	KIAA0319L	1026	Q8IZA0
HGGLGVLPDGQSKLQ	IQSEC2	1251	Q5JU85
GGQPIDANHLNKGIG	HNRNPM	311	P52272
LGQGIGPIHLNEIQC	LOXL2	381	Q9Y4K0
GQQVHLGSAEGPKVS	HLCS	671	P50747
GKGNGPHDNGIIVST	PLXNB2	171	O15031
DIIGVNGQGPNLEGK	NES	1531	P48681
QGPLAKNHGSQGTRL	KIAA2012	246	Q0VF49
VIQTVNHVLQGPGGK	MNT	451	Q99583
HDLVQGSGQQPQAGL	LILRB5	261	O75023
TIIIGGKEQGQPFQG	NRXN1	1251	Q9ULB1
QKLGNGINIIVATPG	DDX18	296	Q9NVP1
HLLGEKILGSLQQGP	PNPLA7	691	Q6ZV29
KILGSLQQGPVTGHQ	PNPLA7	696	Q6ZV29
DGVGINAKLQHPLGV	NHLRC2	466	Q8NBF2
ETLNLGHNPIGNEGV	PPP1R37	336	O75864
GHNPIGNEGVRHLKN	PPP1R37	341	O75864
RNQKGHSGLQPTGFL	HLA-DRB3	251	P79483
QGQHKGSIEGQGPRR	EFCAB5	576	A4FU69
GAEKLPGQGVHSQGQ	GLG1	26	Q92896
INHGPVIAGVIGAQK	ADCY2	1001	Q08462
GVTAEGIHKNLPGNL	ICE1	1861	Q9Y2F5
GILGAQGQEHPGLNV	C5orf67	81	F2Z3F1
LGQHLVQGVISVPKG	GLYCTK	101	Q8IVS8
NEHNGLIKGQIAGGI	FNDC3A	216	Q9Y2H6
VLNKDIQGGIHGTVP	CPAMD8	1256	Q8IZJ3
GQNGPDHALIGGIVA	CADM2	361	Q8N3J6
RNQKGHSGLQPTGFL	HLA-DRB1	251	P01911
PGSVVQQEGLKGEQG	COL22A1	646	Q8NFW1
AGGIGNQHIPGDNSI	DLG3	241	Q92796
RNQKGHSGLQPTGLL	HLA-DRB4	251	P13762
GIVQGLKGDQENVHP	KPNB1	771	Q14974
GHVKPQALDSGQGAA	GP1BA	556	P07359
AGQVQPGKQELGIHL	ITIH6	506	Q6UXX5
APGANHIVGNKLGEE	INSRR	161	P14616
HKQCQLGVLPLGTGN	DGKD	396	Q16760
GKPTAIHQLLTNGGL	KANSL3	821	Q9P2N6
PQVGGVGGDVQILNK	HAS3	236	O00219
PHTEVPQGKGNVLGN	GOLM1	216	Q8NBJ4
GQVAGPGHQRELKAV	CAND2	851	O75155
PNDKQGLSLVNGHVG	SLC39A12	471	Q504Y0
ILLQQQQQLGHGGPE	IRF2BP2	91	Q7Z5L9
GAQLLHGGLQVPQLS	PRR18	211	Q8N4B5
VEGLHINGPTGGNKK	MIER1	421	Q8N108
QKITGGPGLINGRHA	PAMR1	291	Q6UXH9
SPGGSLGGALQKEQH	INVS	661	Q9Y283
QGPHLRHTGQIGGLK	TARS2	241	Q9BW92
GQLGLGHKEDVLLPQ	SERGEF	26	Q9UGK8
LKVGHVGPLQIGQAV	TRIM32	281	Q13049
QGGNLHGQAESPLGI	LARS1	611	Q9P2J5
LSGGHLIQQVINGGK	FBXL18	326	Q96ME1
GHALAGQTSPKQENG	SAMD11	651	Q96NU1
PQKVNINGGAVSLGH	ACAT1	371	P24752
LENPLGQNGLTHQGL	IARS1	1196	P41252
QGAASPGHGIQEKLQ	SP110	376	Q9HB58
VPGAKVALQHNLGIG	SCP2	381	P22307
HQIIDQVLQGGPGKT	CLMN	381	Q96JQ2
LQPGALGKAGGITQV	CIC	811	Q96RK0
RNPTGGKLHIIEVGQ	CLTCL1	221	P53675
GKLHIIEVGQPAAGN	CLTCL1	226	P53675
VGPGHGIQLQSGRLV	NEU3	161	Q9UQ49
GKQHGAVQSGGLNPE	TRPS1	456	Q9UHF7
GAIHAGQPGKVQQLH	PLEK2	101	Q9NYT0
GVQDQPGQHGKTPSL	ZNF714	526	Q96N38
HSLTQNLLKGLQPGG	UBN2	1296	Q6ZU65
NLLKGLQPGGAQHAA	UBN2	1301	Q6ZU65
PKDQHLNGGVQGIQG	UNC13C	601	Q8NB66
ALVPGTIQVNGHGGQ	PHIP	1616	Q8WWQ0
TIQVNGHGGQPSKLV	PHIP	1621	Q8WWQ0
LEQGQQLVAEGHPGA	SPTBN2	701	O15020
GVGGSLKAPVLNLNQ	STBD1	216	O95210
SPQGHGQQGLLQVLK	TBC1D10C	151	Q8IV04
LNHLGALGSDNPGNK	USP29	781	Q9HBJ7
NAHVVPGSGVVKGLQ	UMPS	341	P11172
SLGNIHHKPGGGQVE	MAPT	641	P10636
IGSLDNITHVPGGGN	MAPT	671	P10636
AGLHPGQCIIKVNGI	PREX2	711	Q70Z35
QIALQPALKFNGGGH	SOD2	81	P04179
GKLLLQHGGPVLLQQ	SLF1	891	Q9BQI6
QHGGPVLLQQRNAKG	SLF1	896	Q9BQI6
GIGLPHSENNQDKGL	YLPM1	986	P49750
ELLIGNNPEVGKGTH	TGM1	166	P22735
GEAGSLQGPVLQHQS	THRA	421	P10827
LVPTANLNHSVGKGG	WDR24	461	Q96S15
NIRGNKQAQGTGHEP	TBC1D2	221	Q9BYX2
GIGGQFLKHQAEAQP	ZNF500	151	O60304
HLNVINDGGPQNGLV	VPS54	931	Q9P1Q0